This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Nautilus, Inc. Reports Results For The Fourth Quarter And Full Year 2012

For the fourth quarter of 2012, the Company reported net income (including discontinued operation) of $13.6 million, or $0.44 per diluted share, compared to $3.2 million, or $0.10 per diluted share, for the fourth quarter of 2011. Net income for the fourth quarter of 2012 included $6.2 million from the non-cash recognition of currency translation adjustments related to foreign entities of the discontinued operation. Excluding recognition of currency translation adjustments, net income for the fourth quarter of 2012 was $7.4 million, or $0.24 per diluted share.

For the full year 2012, the Company reported net income (including discontinued operation) of $16.9 million, or $0.55 per diluted share, compared to net income of $1.4 million, or $0.05 per diluted share, for 2011. Net income for 2012 included $6.2 million from the non-cash recognition of currency translation adjustments related to foreign entities of the discontinued operation. Excluding recognition of currency translation adjustments, net income for 2012 was $10.7 million, or $0.35 per diluted share.

Mr. Cazenave continued, “As we begin 2013, we are encouraged by the overall position of our more efficient business platform and expanding portfolio of products. New products will continue to be a key driver of the growth and profitability improvement in the business. While it is still early, we are pleased with the initial consumer reception to our newest products and are optimistic that they will contribute to our top and bottom lines in coming quarters.”

For further information, see "Results of Operations Information" attached hereto.

Segment Results

Net sales for the Direct segment were $41.4 million in the fourth quarter of 2012, an increase of 30.7% over the comparable period last year, reflecting strong demand for the Company's cardio products driven by increased advertising and call center effectiveness and higher U.S. consumer credit approval rates. U.S. credit approval rates rose to 37% in the fourth quarter of 2012, up from 30% for the same period last year. Fourth quarter 2012 sales also benefitted from sales of CoreBody Reformer following its relaunch in the third quarter of 2012.

2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,034.93 +208.63 1.17%
S&P 500 2,100.40 +19.22 0.92%
NASDAQ 4,994.6020 +62.7870 1.27%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs